IBUPROFEN DOES NOT IMPROVE DISCONTINUATION RATES OF INTRAUTERINE DEVICES (IUDs): Hubacher D, Reyes V, Lillo S, Pierre-Louis B, Zepeda A, Chen P-A, et al. Preventing copper intrauterine device removals due to side effects among first-time users; randomized

2006 ◽  
Vol 51 (6) ◽  
pp. 523-524
Author(s):  
Carol Snapp
Keyword(s):  
Side Effects ◽  
Intrauterine Device ◽  
Intrauterine Devices ◽  
First Time ◽  
Copper Intrauterine Device

scholarly journals Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen

2006 ◽  
Vol 21 (6) ◽  
pp. 1467-1472 ◽  
Author(s):  
David Hubacher ◽  
Veronica Reyes ◽  
Sonia Lillo ◽  
Bosny Pierre-Louis ◽  
Ana Zepeda ◽  
...  
Keyword(s):  
Side Effects ◽  
Randomized Trial ◽  
Intrauterine Device ◽  
First Time ◽  
Copper Intrauterine Device

scholarly journals Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury

2017 ◽  
Vol 11 (3) ◽  
pp. 742-747 ◽  
Author(s):  
Hira Imad Cheema ◽  
Ashutosh Gupta
Keyword(s):  
Side Effects ◽  
Liver Injury ◽  
Liver Biopsy ◽  
Oral Contraceptives ◽  
Acute Liver Injury ◽  
Intrauterine Device ◽  
Intrauterine Devices ◽  
Metabolic Side Effects ◽  
First Time

Oral contraceptives have long been associated with liver injury. However, very little attention is paid to the metabolic side effects of hormone-releasing intrauterine devices (IUDs). These devices are generally considered safe and commonly used. We report for the first time acute liver injury associated with a levonorgestrel-releasing IUD. Our patient did not have any comorbidities that could have caused or exacerbated liver injury. A detailed workup and liver biopsy remained negative for any other potential cause of liver injury. The patient’s symptoms resolved with removal of the device. She remained symptom free on subsequent outpatient follow-ups.

Higher discontinuation rate with a standard-sized compared to a small-sized ‘gold standard’ copper intrauterine device: a case-control review

2019 ◽  
Vol 45 (4) ◽  
pp. 263-268 ◽  
Author(s):  
Hannat Akintomide ◽  
Pam Barnes ◽  
Nataliya Brima ◽  
Diana Mansour
Keyword(s):  
Surface Area ◽  
Gold Standard ◽  
Intrauterine Device ◽  
Copper Surface ◽  
Case Control ◽  
Discontinuation Rate ◽  
Intrauterine Devices ◽  
Copper Surface Area ◽  
Clinical Records ◽  
Copper Intrauterine Device

BackgroundT-shaped intrauterine devices (IUDs) with a copper surface area of 380 mm2 and copper bands on the transverse arms are the most effective types of copper-containing IUDs. A small-sized ‘gold standard’ IUD is available but there has been little research to compare the effects of this small-sized IUD to its standard-sized counterpart.AimTo determine discontinuation rates and reasons for discontinuation at 1 year of the small-sized Mini TT380 Slimline IUD compared with the standard-sized TT380 Slimline.MethodsThe clinical records of women fitted with Mini TT380 Slimline (‘mini’) IUDs were compared with those of women fitted with standard-sized TT380 Slimline (‘standard’) IUDs over a 3-year period (2013–2016).ResultsClinical records were available for 67 women fitted with a mini IUD (mean age 23 years, 64% nulliparous) and 63 women fitted with a standard IUD (mean age 25 years, 39% nulliparous). At 1 year, twice as many standard IUD users (32%, n=20) had discontinued their IUD use compared with mini IUD users (15%, n=10). Complaints of pain and bleeding were more than double (70%, n=14) in those women who discontinued standard IUD use compared with those who discontinued using the mini IUD (30%, n=3). These differences were statistically significant and were unrelated to parity.ConclusionsMore women using a standard-sized ‘gold standard’ IUD rather than its smaller counterpart complained of pain and bleeding, leading to higher discontinuation at 1 year. More research on the association between size and discontinuation of these IUDs is needed.

A suspicious reason for Raynaud’s phenomenon: Intrauterine device

Vascular ◽  
2014 ◽  
Vol 23 (3) ◽  
pp. 327-328
Author(s):  
Adem İ Diken ◽  
Adnan Yalçınkaya ◽  
Eray Aksoy ◽  
Seyhan Yılmaz ◽  
Kerim Çağlı
Keyword(s):  
Medical Therapy ◽  
Raynaud’S Phenomenon ◽  
Intrauterine Device ◽  
Raynaud's Phenomenon ◽  
Sex Hormone ◽  
Intrauterine Devices ◽  
Postmenopausal Patient ◽  
Hormone Status ◽  
Primary Raynaud’S Phenomenon ◽  
Copper Intrauterine Device

Primary Raynaud’s phenomenon may be insistent in patients under medical therapy, and intrauterine devices may be an unnoticed reason in these patients. Fluctuations in female sex hormone status were reported to be associated with the emergence of primary Raynaud’s phenomenon symptoms. The use of intrauterine devices was not reported to be associated with Raynaud’s phenomenon previously. Intrauterine device may stimulate vascular hyperactivity regarding hormonal or unknown mechanisms that result in Raynaud’s phenomenon. We present a postmenopausal patient who complained of primary Raynaud’s phenomenon symptoms and had recovery after the removal of her copper intrauterine device.

Subendometrial microvascularization and uterine artery blood flow in IUD-induced side effects (levonorgestrel intrauterine system and copper intrauterine device)

Contraception ◽  
2008 ◽  
Vol 78 (4) ◽  
pp. 324-327 ◽  
Author(s):  
Mirela F. Jiménez ◽  
Daniela Vetori ◽  
Paulo A.P. Fagundes ◽  
Fernando M. de Freitas ◽  
João S.L. Cunha-Filho
Keyword(s):  
Blood Flow ◽  
Side Effects ◽  
Uterine Artery ◽  
Intrauterine Device ◽  
Artery Blood Flow ◽  
Copper Intrauterine Device

CONTRACEPTION IN DIABETIC PATIENTS

1974 ◽  
Vol 77 (3_Suppl) ◽  
pp. S87-S94 ◽  
Author(s):  
J. Wiese ◽  
M. Osler
Keyword(s):  
Side Effects ◽  
Contraceptive Method ◽  
Low Dose ◽  
Unplanned Pregnancy ◽  
Intrauterine Device ◽  
Diabetic Patients ◽  
Intrauterine Contraception ◽  
Unwanted Pregnancies ◽  
Unreliable Method ◽  
Retrospective Investigation

ABSTRACT A retrospective investigation was made of contraception in diabetic women delivered in our department in 1969 and 1970. Seventy-nine (69 per cent) answered the questionnaires. About one third had found the contraceptive instruction insufficient. A shift from conventional to intrauterine contraception and sterilization was seen, but nearly 25% of the patients were still using conventional methods, mainly the condom. The patients consider this an unreliable method. Thirty-three patients were using intrauterine contraception. Although 10 of them had bleeding irregularities, all were satisfied with the method. Sterilization had been performed on 17 patients, all of whom were fully satisfied and had experienced no side effects. Four of 11 insulin-requiring diabetics, who have used combined oestrogen-progesterone medication have had difficulties in the regulation of the diabetes. Of 24 unwanted pregnancies 12 occurred since the hospitalization in 1969 and 1970. In diabetic women the contraceptive method should either be sterilization, intrauterine device or low dose progestagens, and only in a few cases conventional. A thorough contraceptive instruction as well as a close control of the diabetic women are of importance in order to avoid unplanned pregnancy. The best way to achieve this is by having an out-patient clinic in connection with the obstetrical department to supervise contraception in all diabetic women in the area.

Sign in / Sign up

Export Citation Format

Share Document